Jankowski Jakub, Lee Hye Kyung, Wilflingseder Julia, Hennighausen Lothar
Laboratory of Genetics and Physiology, National Institute of Diabetes and Digestive and Kidney Diseases, U.S. National Institutes of Health, Bethesda, MD 20892, USA.
Department of Physiology and Pathophysiology, University of Veterinary Medicine, Veterinärplatz 1, 1210, Vienna, Austria.
bioRxiv. 2021 Jan 19:2021.01.15.426908. doi: 10.1101/2021.01.15.426908.
Recently, a short, interferon-inducible isoform of Angiotensin-Converting Enzyme 2 (ACE2), dACE2 was identified. ACE2 is a SARS-Cov-2 receptor and changes in its renal expression have been linked to several human nephropathies. These changes were never analyzed in context of , as its expression was not investigated in the kidney. We used Human Primary Proximal Tubule (HPPT) cells to show genome-wide gene expression patterns after cytokine stimulation, with emphasis on the locus. Putative regulatory elements controlling expression were identified using ChIP-seq and RNA-seq. qRT-PCR differentiating between and revealed 300- and 600-fold upregulation of by IFNα and IFNβ, respectively, while full length expression was almost unchanged. JAK inhibitor ruxolitinib ablated and expression after interferon treatment. Finally, with RNA-seq, we identified a set of genes, largely immune-related, induced by cytokine treatment. These gene expression profiles provide new insights into cytokine response of proximal tubule cells.
最近,发现了一种短的、干扰素诱导型血管紧张素转换酶2(ACE2)同工型,即dACE2。ACE2是一种新冠病毒受体,其在肾脏中的表达变化与几种人类肾病有关。由于其在肾脏中的表达未被研究,这些变化从未在相关背景下进行分析。我们使用人原代近端小管(HPPT)细胞来展示细胞因子刺激后的全基因组基因表达模式,重点关注该基因座。使用染色质免疫沉淀测序(ChIP-seq)和RNA测序(RNA-seq)鉴定了控制该基因表达的假定调控元件。区分该基因不同亚型的定量逆转录聚合酶链反应(qRT-PCR)显示,干扰素α和干扰素β分别使该基因上调300倍和600倍,而全长ACE2的表达几乎没有变化。JAK抑制剂鲁索替尼在干扰素治疗后消除了该基因和全长ACE2的表达。最后,通过RNA测序,我们鉴定了一组主要由细胞因子治疗诱导的、与免疫相关的基因。这些基因表达谱为近端小管细胞的细胞因子反应提供了新的见解。